Changeflow GovPing Government & Legislation National Health Act - Commonwealth Pharmaceutic...
Routine Rule Amended Final

National Health Act - Commonwealth Pharmaceutical Benefits Pricing Determination 2019 (April 2026)

Favicon for www.legislation.gov.au AU Federal Legislative Instruments (7-day)
Published
Detected
Email

Summary

The Australian Department of Health, Disability and Ageing has issued an amendment to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019, effective 1 April 2026. This legislative instrument sets Commonwealth prices and payment conditions for pharmaceutical benefits supplied under the Pharmaceutical Benefits Scheme by approved pharmacists and approved medical practitioners. The Determination includes schedules covering ready-prepared pharmaceutical benefits, unstable or sterile ingredients, dangerous drug fees, complete pack requirements, and standard formula preparations.

Published by DoH AU on legislation.gov.au . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This legislative instrument amends the Commonwealth price and conditions for payments for the supply of pharmaceutical benefits under the National Health Act 1953. The Determination establishes pricing for pharmaceutical benefits supplied by approved medical practitioners and sets conditions on payments to approved pharmacists and approved medical practitioners, including requirements for complete packs and dangerous drug fees.

Approved pharmacists and approved medical practitioners supplying pharmaceutical benefits under the PBS must comply with the pricing and conditions set out in this Determination. Pharmaceutical manufacturers supplying PBS-listed medicines should review updated pricing arrangements. The schedules specify which pharmaceutical benefits require complete pack supply, dangerous drug fees apply, or standard formula preparations are permitted.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

- Interactions

National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019

In force Administered by
- Department of Health, Disability and Ageing
This item is authorised by the following title:


View document Legislative instrument Filter active Table of contents
- Part 1—Preliminary
- 1 Name
- 3 Authority
- 5 Simplified outline of this instrument
- 6 Definitions
- Part 2—Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners
- 7 Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners
- Part 3—Conditions on payments for pharmaceutical benefits supplied by approved pharmacists and approved medical practitioners
- 8 Scope of this Part
- 9 Condition on payment for supply of certain pharmaceutical items
- 10 Payment for supply of certain pharmaceutical benefits in complete packs
- Schedule 1—Ready-prepared pharmaceutical benefits that are mixtures of ready-prepared ingredients
- Schedule 2—Unstable or sterile ingredients used for extemporaneously-prepared pharmaceutical benefits
- Schedule 3—Pharmaceutical benefits for which a dangerous drug fee applies
- Schedule 4—Pharmaceutical benefits to be supplied as complete packs only
- Schedule 5—Standard formula preparations
- 1 Standard formula preparations
- Endnotes
- Endnote 1—About the endnotes
- Endnote 2—Abbreviation key
- Endnote 3—Legislation history
- Endnote 4—Amendment history

Named provisions

Part 1—Preliminary Part 2—Commonwealth price for pharmaceutical benefits supplied by approved medical practitioners Part 3—Conditions on payments for pharmaceutical benefits supplied by approved pharmacists and approved medical practitioners Schedule 1—Ready-prepared pharmaceutical benefits that are mixtures of ready-prepared ingredients Schedule 2—Unstable or sterile ingredients used for extemporaneously-prepared pharmaceutical benefits Schedule 3—Pharmaceutical benefits for which a dangerous drug fee applies Schedule 4—Pharmaceutical benefits to be supplied as complete packs only Schedule 5—Standard formula preparations

Get daily alerts for AU Federal Legislative Instruments (7-day)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DoH AU.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DoH AU
Published
April 1st, 2026
Instrument
Rule
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
F2020L00059
Supersedes
F2020L00059

Who this affects

Applies to
Healthcare providers Pharmaceutical companies Government agencies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Pharmaceutical pricing PBS payments Payment conditions
Geographic scope
Australia AU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Healthcare Government Contracting Pricing

Get alerts for this source

We'll email you when AU Federal Legislative Instruments (7-day) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!